Jiang Pi
Guangdong Provincial Key Laboratory Of Medical Immunology And Molecular Diagnostics
Dongguan, China
Dongguan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications
Bilateral SERS-Microneedle Patch for Co-Diagnosis of Diabetes Mellitus and Tuberculosis Comorbidity.
Bilateral SERS-Microneedle Patch for Co-Diagnosis of Diabetes Mellitus and Tuberculosis Comorbidity.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 18, 2026
Investigating the role of baseline gut Akkermansia muciniphila and its co-metabolite palmitoleic acid in BCG vaccine efficacy: a preclinical study.
Journal: EBioMedicine
Published: December 03, 2025
SERS Facemask for Rapid and Portable Sensing Mycobacterium Tuberculosis Antigens for TB Screening.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 23, 2025
Bacillus subtilis G01: A Multifunctional Agent with Broad-Spectrum Antimicrobial Activity and Digestive Enzymes for Sustainable Agriculture and Animal Husbandry.
Journal: Journal of microbiology and biotechnology
Published: October 28, 2025
Mycobacterium tuberculosis-induced PCBP1 degradation drives macrophage ferroptosis to promote infection: a lung-macrophage-targeted RNAa nanotherapy.
Journal: Journal of nanobiotechnology
Published: September 10, 2025
Advancements in photodynamic therapy for tuberculosis treatment.
Journal: Microbial pathogenesis
Published: August 31, 2025
Corrigendum to "miR-146a-5p targets IRAK1/TRAF6 to promote bacillus Calmette-Guérin survival by exosome-mediated autocrine actions" [Mol. Immunol. 185, Article number 7117].
Journal: Molecular immunology
Published: August 22, 2025
Poly (allylamine hydrochloride)-selenium nanoparticles inhibit porcine reproductive and respiratory syndrome virus by targeting DDX5 and reactive oxygen species.
Journal: Antiviral research
Published: August 20, 2025
Exosomal co-delivery of CircRNA-TRAPPC6B and rifampicin for enhanced immunotherapy against tuberculosis.
Journal: International immunopharmacology
Published: July 27, 2025
Macrophage targeted cellular microparticles synergize anti-tuberculosis therapy combining CircRNA-mediated host immune defense and antibiotic killing.
Journal: Materials today. Bio
Published: June 29, 2025
Immune defense and immune evasion in Mycobacterium tuberculosis Infection: Inspirations and challenges for host directed therapy.
Journal: Microbial pathogenesis
Published: May 22, 2025
Stress granules and cell death: crosstalk and potential therapeutic strategies in infectious diseases.
Journal: Cell death & disease
Published: April 16, 2025
Last Updated: 09/26/2026